


Chlamydia, a silent but rampant STI caused by Chlamydia trachomatis, is often asymptomatic—up to 70% in women and 50% in men never realize they’re infected. If left untreated, it can lead to serious long-term health issues. This comprehensive blog dives into the extended impacts of chlamydia, aiming to inform patients, providers, and wellness advocates on prevention, diagnosis, and long-term vigilance.
One of the most concerning long-term outcomes for women is pelvic Inflammatory Disease (PID). Chlamydia is responsible for roughly 50% of PID cases, and an estimated 10–30% of women with genital chlamydia go on to develop PID. Without treatment, a staggering 10–15% will develop PID within just a couple of weeks. Chronic PID may result in infertility, ectopic pregnancies, and long-term pelvic pain, which overall threatens both physical and mental health.
PID often damages the fallopian tubes, leading to infertility and the risk of ectopic pregnancy—an early-gestation emergency. Estimates suggest 40% of ectopic pregnancies are linked to chlamydia-related tubal scarring. Indeed, tubal factor infertility accounts for 25–30% of female infertility, frequently rooted in prior chlamydia infection.
Expectant mothers with untreated chlamydia risk transmitting the infection during childbirth. About 50% of newborns born to infected mothers are affected. These infants face risks of neonatal conjunctivitis—potentially causing blindness—and pneumonia in the weeks following birth.
Men are not immune. Though less common, chlamydia can cause epididymitis, inflammation of the testicular epididymis. Symptoms include swelling, discharge, and testicular pain. Left unchecked, this could trigger epididymo-orchitis and may contribute to infertility.
Chlamydia can also trigger reactive arthritis, an inflammatory condition with joint pain, eye, and urinary symptoms. This condition typically affects men aged 20–40, developing weeks to months after the initial infection. In the U.S., ~15,000 men are diagnosed each year, including around 5,000 who experience chronic symptoms
Even absence of PID, chronic chlamydia infections can lead to pelvic or abdominal pain, tubal scarring, reduced fertility, and increased ectopic pregnancy risk. In women, tubal factor infertility is a top long-term complication. Moreover, chronic discomfort profoundly disrupts emotional well-being and quality of life.
Chlamydia treatment commonly involves doxycycline, taken for at least 7 days. For doxy-PEP prevention strategies or extended therapy, studies show longer-term use (8+ weeks) is typically safe, though gastrointestinal and skin-related side effects occur in up to 50% of cases. Discontinuation is rare, but more data is needed on metabolic impacts
Recent guidance from the CDC recommends 200 mg of doxycycline within 72 hours post-sex for high-risk individuals—MSM and TGW with recent bacterial STIs—to reduce chlamydia reinfection risk by over 70%. DoxyPEP is new, promising, but requires safe protocols and long-term monitoring.
Chlamydia is routinely tested via urine or swabs from sexual sites. Despite high case numbers (1.6 million reported in 2023 in the U.S.) and STI totals around 2.4 million, many infections go undetected. This “silent” nature reinforces the need for regular screening, especially in sexually active individuals under 25 or with multiple partners.
Repeat chlamydia infections are common, often due to untreated partners or unprotected sex. Each recurrence escalates the risk of PID, fertility problems, and chronic reproductive health issues. Ensuring partner notification and treatment is critical.
Consistent use of condoms and limiting partners significantly reduces STI risk.
Frequent STI screenings (at least annually, or more for high-risk individuals under 25).
Immediate and complete doxycycline treatment —standard 7-day regimen for infected individuals.
Consider doxy-PEP post sex for those at high risk, following CDC guidelines.
Educate patients on reinfection and the importance of treating partners.
Monitor symptoms like PID, pelvic pain, epididymo-orchitis, or joint inflammation early.
Long term effects of chlamydia—PID, infertility, ectopic pregnancy, neonatal complications, epididymitis, and reactive arthritis—underscore its public health significance. Early detection, consistent treatment, partner care, and adoption of doxyPEP for high-risk groups are vital. Educators, health professionals, and platforms like B Brand can use this information to empower and protect communities.
B Brand is a telehealth company focused on delivering premium quality sexual health products, paired with education and resources to help people make informed decisions. We are your one-stop destination for all your intimate health needs.
To complete a B Brand consultation, all you need to do is answer our quick online medical questions. Your answers are then reviewed by our US medical team, who will decide if you are eligible for treatment, and which medication is best for you.
Doxy-PEP means taking the antibiotic doxycycline after sex, to prevent getting an STI. It is like a morning-after pill but for STIs. Taking doxy-PEP reduces your chance of acquiring syphilis, gonorrhea, and chlamydia by about two-thirds.
Two 100 mg pills of doxycycline should be taken ideally within 24 hours but no later than 72 hours after condomless sex. Condomless sex means oral, anal or vaginal/front-hole sex where a condom isn’t used for the entire time.
If you have sex again within 24 hours of taking doxycycline, take another dose 24 hours after your last dose. You can take doxycycline as often as every day when you are having condomless sex but don’t take more than 200 mg (two 100 mg pills) every 24 hours.
• Take doxycycline with plenty of water or something else to drink so that it does not get stuck when you swallow. If your stomach is upset by doxycycline, taking it with food may help.
• Some people are more sensitive to the sun when they take doxycycline, so wear sunscreen.
• Please do not share doxycycline with others.
• Avoid dairy products, calcium, antacids, or multivitamins 2 hours before after taking doxycycline